avetlx63mcraptor| Shanghai Pharmaceutical: The subsidiary company's metoclopramide hydrochloride injection passed consistency evaluation
News summary [Shanghai Pharmaceutical: Subsidiary Metoclopramide Hydrochloride Injection Passed Consistency Evaluation] Securities Times e Company News, Shanghai Pharmaceutical (601607)